• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4 谱系特化的奥秘。

The enigma of CD4-lineage specification.

机构信息

Laboratory of Immune Cell Biology, Center for Cancer Research (CCR), NCI, NIH, Bethesda, MD 20892-4259, USA.

出版信息

Eur J Immunol. 2011 Mar;41(3):568-74. doi: 10.1002/eji.201041098. Epub 2011 Feb 10.

DOI:10.1002/eji.201041098
PMID:21341258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3388806/
Abstract

CD4(+) T cells are essential for defenses against pathogens and affect the functions of most cells involved in the immune response. Although CD4(+) T cells generally recognize peptide antigens bound to MHC-II molecules, important subsets are restricted by other MHC or MHC-like molecules, including CD1d-restricted "invariant" iNK T cells. This review discusses recently identified nodes in the transcriptional circuits that are involved in controlling CD4(+) T-cell differentiation, notably the commitment factor Thpok and its interplay with Runx transcriptional regulators, and focuses on how transcription factors acting upstream of Thpok, including Gata3, Tox and E-box proteins, promote the emergence of CD4-lineage-specific gene expression patterns.

摘要

CD4(+) T 细胞对于抵御病原体至关重要,并且影响参与免疫反应的大多数细胞的功能。尽管 CD4(+) T 细胞通常识别与 MHC-II 分子结合的肽抗原,但重要的亚群受到其他 MHC 或 MHC 样分子的限制,包括 CD1d 限制的“不变”iNK T 细胞。本综述讨论了最近发现的参与控制 CD4(+) T 细胞分化的转录回路中的节点,特别是决定因子 Thpok 及其与 Runx 转录因子的相互作用,并重点介绍了在 Thpok 上游起作用的转录因子,包括 Gata3、Tox 和 E 盒蛋白,如何促进 CD4 谱系特异性基因表达模式的出现。

相似文献

1
The enigma of CD4-lineage specification.CD4 谱系特化的奥秘。
Eur J Immunol. 2011 Mar;41(3):568-74. doi: 10.1002/eji.201041098. Epub 2011 Feb 10.
2
CD4-CD8 lineage differentiation: Thpok-ing into the nucleus.CD4-CD8谱系分化:Thpok进入细胞核。
J Immunol. 2009 Sep 1;183(5):2903-10. doi: 10.4049/jimmunol.0901041.
3
An Integrated Epigenomic and Transcriptomic Map of Mouse and Human αβ T Cell Development.小鼠和人类 αβ T 细胞发育的综合表观基因组和转录组图谱。
Immunity. 2020 Dec 15;53(6):1182-1201.e8. doi: 10.1016/j.immuni.2020.10.024. Epub 2020 Nov 25.
4
Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells.转录因子GATA-3和ThPOK在CD4(+) T细胞胸腺内分化过程中的不同功能。
Nat Immunol. 2008 Oct;9(10):1122-30. doi: 10.1038/ni.1647. Epub 2008 Sep 7.
5
Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.Runx3转录因子的过表达增加了CD8单阳性谱系成熟胸腺细胞的比例。
J Immunol. 2005 Mar 1;174(5):2627-36. doi: 10.4049/jimmunol.174.5.2627.
6
A Fateful Decision in the Thymus Controlled by the Transcription Factor ThPOK.由转录因子ThPOK控制的胸腺中的一个重大决定。
J Immunol. 2021 May 1;206(9):1981-1982. doi: 10.4049/jimmunol.2100157.
7
CD4 CTL: living up to the challenge.CD4 CTL:迎接挑战。
Semin Immunol. 2013 Nov 15;25(4):273-81. doi: 10.1016/j.smim.2013.10.022.
8
CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus.CD4⁺CD8⁺细胞谱系定向由ThPOK转录因子基因座处的一个沉默子元件调控。
Immunity. 2008 Mar;28(3):346-58. doi: 10.1016/j.immuni.2008.02.006.
9
Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus.胸腺中 CD4+T 细胞分化过程中 Thpok 非依赖性 Gata3 对 Runx3 的抑制作用。
Eur J Immunol. 2013 Apr;43(4):918-28. doi: 10.1002/eji.201242944. Epub 2013 Feb 12.
10
CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.在Ly-6A.2转基因小鼠中,CD4+ T细胞在缺乏MHC I类和II类分子表达的情况下成熟。
J Immunol. 1998 Jul 1;161(1):175-82.

引用本文的文献

1
Aryl Hydrocarbon Receptor (AHR) Suppresses Arsenic (As)-Induced Malignant Transformation by Antagonizing TOX Expression.芳烃受体(AHR)通过拮抗TOX表达抑制砷(As)诱导的恶性转化。
Int J Biol Sci. 2025 Mar 31;21(6):2747-2761. doi: 10.7150/ijbs.107268. eCollection 2025.
2
A Beginner's Guide to T Cell Development.T 细胞发育入门指南。
Methods Mol Biol. 2023;2580:3-24. doi: 10.1007/978-1-0716-2740-2_1.
3
Functional and molecular characterization of PD1 tumor-infiltrating lymphocytes from lung cancer patients.从肺癌患者肿瘤浸润淋巴细胞中鉴定 PD1 的功能和分子特征。

本文引用的文献

1
Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages.淋巴组织诱导细胞和自然杀伤细胞谱系的发育依赖于 DNA 结合因子 TOX。
Nat Immunol. 2010 Oct;11(10):945-52. doi: 10.1038/ni.1930. Epub 2010 Sep 5.
2
The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells.Gata3 和 Thpok 的顺序活性对于 CD1d 限制性 CD4+ NKT 细胞的分化是必需的。
Eur J Immunol. 2010 Sep;40(9):2385-90. doi: 10.1002/eji.201040534.
3
Decision checkpoints in the thymus.
Oncoimmunology. 2022 Feb 9;11(1):2019466. doi: 10.1080/2162402X.2021.2019466. eCollection 2022.
4
Tle corepressors are differentially partitioned to instruct CD8 T cell lineage choice and identity.Tle 核心抑制因子被差异化分配以指导 CD8 T 细胞谱系选择和身份。
J Exp Med. 2018 Aug 6;215(8):2211-2226. doi: 10.1084/jem.20171514. Epub 2018 Jul 25.
5
Identification of lineage-specifying cytokines that signal all CD8-cytotoxic-lineage-fate 'decisions' in the thymus.鉴定在胸腺中对所有CD8细胞毒性谱系命运“决定”发出信号的谱系特异性细胞因子。
Nat Immunol. 2017 Nov;18(11):1218-1227. doi: 10.1038/ni.3847. Epub 2017 Sep 25.
6
The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling.转录因子 ThPOK 通过诱导细胞因子信号转导的 SOCS 抑制物来抑制 Runx3 并赋予 CD4(+) 谱系命运。
Nat Immunol. 2014 Jul;15(7):638-45. doi: 10.1038/ni.2917. Epub 2014 Jun 1.
7
A silencer-proximal intronic region is required for sustained CD4 expression in postselection thymocytes.沉默子近端内含子区域是后期选择的胸腺细胞中持续 CD4 表达所必需的。
J Immunol. 2014 May 15;192(10):4620-7. doi: 10.4049/jimmunol.1302374. Epub 2014 Apr 11.
8
The transcription factors Thpok and LRF are necessary and partly redundant for T helper cell differentiation.转录因子 Thpok 和 LRF 对于辅助性 T 细胞分化是必要的且部分冗余的。
Immunity. 2012 Oct 19;37(4):622-33. doi: 10.1016/j.immuni.2012.06.019. Epub 2012 Oct 4.
9
CD4-CD8 differentiation in the thymus: connecting circuits and building memories.胸腺中 CD4-CD8 分化:连接回路与构建记忆
Curr Opin Immunol. 2012 Apr;24(2):139-45. doi: 10.1016/j.coi.2012.02.002. Epub 2012 Mar 2.
10
Role of Hedgehog signalling at the transition from double-positive to single-positive thymocyte.Hedgehog 信号在双阳性向单阳性胸腺细胞过渡中的作用。
Eur J Immunol. 2012 Feb;42(2):489-99. doi: 10.1002/eji.201141758. Epub 2011 Dec 16.
胸腺中的决策检查点。
Nat Immunol. 2010 Aug;11(8):666-73. doi: 10.1038/ni.1887. Epub 2010 Jul 20.
4
TCR-mediated ThPOK induction promotes development of mature (CD24-) gammadelta thymocytes.TCR 介导的 ThPOK 诱导促进成熟(CD24-)γδ胸腺细胞的发育。
EMBO J. 2010 Jul 21;29(14):2329-41. doi: 10.1038/emboj.2010.113. Epub 2010 Jun 15.
5
Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.在未知领域中艰难前行:从 T 细胞受体信号到胸腺细胞选择过程中的效应基因表达。
Semin Immunol. 2010 Oct;22(5):294-302. doi: 10.1016/j.smim.2010.04.013.
6
Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection.V alpha14i NKT 细胞的共受体选择受 Th-POK 表达驱动,而不是避免 CD8 介导的负选择。
J Exp Med. 2010 May 10;207(5):1015-29. doi: 10.1084/jem.20090557. Epub 2010 Apr 19.
7
The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes.锌指蛋白 MAZR 是转录因子网络的一部分,该网络控制双阳性胸腺细胞的 CD4 与 CD8 谱系命运。
Nat Immunol. 2010 May;11(5):442-8. doi: 10.1038/ni.1860. Epub 2010 Apr 11.
8
The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage.转录因子 c-Myb 为 CD4+CD8+未成熟胸腺细胞进入 iNKT 细胞谱系的选择做好准备。
Nat Immunol. 2010 May;11(5):435-41. doi: 10.1038/ni.1865. Epub 2010 Apr 11.
9
Epigenetic propagation of CD4 expression is established by the Cd4 proximal enhancer in helper T cells.辅助性 T 细胞中的 Cd4 近端增强子建立了 CD4 表达的表观遗传传播。
Genes Dev. 2010 Apr 1;24(7):659-69. doi: 10.1101/gad.1901610.
10
The role of ThPOK in control of CD4/CD8 lineage commitment.转录激活因子 ThPOK 在调控 CD4/CD8 谱系定向中的作用。
Annu Rev Immunol. 2010;28:295-320. doi: 10.1146/annurev.immunol.25.022106.141715.